189 related articles for article (PubMed ID: 36211569)
1. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions.
Yang X; Lu W; Pan L; Han Z; Pan S; Wang X; Zhu Y; Shan Y; Peng M; Qin P; Zhang P; Qin X; Sun G; Qin Z; Dong J; Qiu C
Front Cardiovasc Med; 2022; 9():935263. PubMed ID: 36211569
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in
Wang X; Yang X; Lu W; Pan L; Han Z; Pan S; Shan Y; Wang X; Zheng X; Li R; Zhu Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
Front Cardiovasc Med; 2023; 10():1045859. PubMed ID: 36937919
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
4. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
Mitsui K; Lee T; Miyazaki R; Hara N; Nagamine S; Nakamura T; Terui M; Okata S; Nagase M; Nitta G; Watanabe K; Kaneko M; Nagata Y; Nozato T; Ashikaga T
Catheter Cardiovasc Interv; 2023 Jul; 102(1):11-17. PubMed ID: 37210618
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Drug-Coated Balloon Approaches for
Zhong PY; Ma Y; Shang YS; Niu Y; Bai N; Wang ZL
Front Cardiovasc Med; 2022; 9():899701. PubMed ID: 35800174
[TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: A patient-level propensity-matched analysis.
Pan L; Lu W; Han Z; Pan S; Wang X; Shan Y; Peng M; Qin X; Sun G; Zhang P; Dong J; Qiu C
Front Cardiovasc Med; 2022; 9():1028007. PubMed ID: 36407423
[TBL] [Abstract][Full Text] [Related]
7. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
[TBL] [Abstract][Full Text] [Related]
8. Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease-a meta-analysis.
Felbel D; Bozic F; Mayer B; Krohn-Grimberghe M; Paukovitsch M; d'Almeida S; Mörike J; Gonska B; Imhof A; Buckert D; Rottbauer W; Markovic S; Stephan T
Front Cardiovasc Med; 2023; 10():1213992. PubMed ID: 37671137
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of drug-coated balloon versus drug-eluting stent for
Lin L; Lu W; Wang X; Pan L; Wang X; Zheng X; Li R; Shan Y; Peng M; Qiu C
Front Cardiovasc Med; 2023; 10():982880. PubMed ID: 36950290
[TBL] [Abstract][Full Text] [Related]
10. Stentless at ostium: a novel approach for treating ostial left anterior descending or left circumflex coronary artery lesions with drug-coated balloons.
Lu WJ; Pan L; Han ZY; Pan SC; Wang X; Shan YG; Peng M; Qin XF; Sun GJ; Zhang PS; Dong JZ; Qiu CG
Am J Transl Res; 2022; 14(9):6256-6267. PubMed ID: 36247262
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
Her AY; Kim B; Ahn SH; Park Y; Cho JR; Jeong YH; Shin ES
Yonsei Med J; 2023 Jun; 64(6):359-365. PubMed ID: 37226562
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
[TBL] [Abstract][Full Text] [Related]
13. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
14. Prospective, single-centre evaluation of the safety and efficacy of percutaneous coronary interventions following a decision tree proposing a no-stent strategy in stable patients with coronary artery disease (SCRAP study).
Meunier L; Godin M; Souteyrand G; Mottin B; Valy Y; Lordet V; Benoit C; Bakdi R; Laurençon V; Genereux P; Waliszewski M; Allix-Béguec C
Clin Res Cardiol; 2023 Sep; 112(9):1164-1174. PubMed ID: 35776144
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
16. Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels.
Iwasaki Y; Koike J; Ko T; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
Heart Vessels; 2021 Feb; 36(2):189-199. PubMed ID: 32857188
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV
Clin Res Cardiol; 2023 Jul; ():. PubMed ID: 37495797
[TBL] [Abstract][Full Text] [Related]
18. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
19. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
[TBL] [Abstract][Full Text] [Related]
20. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
